Phage Therapy 2026 invites researchers, clinicians, startups, and industry partners to present new solutions that move phage therapy forward in a concrete and operational way.
The objective is simple:
Identify solutions that make phage therapy scientifically solid, clinically credible, and industrially deployable in the fight against antimicrobial resistance.
We are looking for projects that solve real problems in the field, such as:
- Better ways to match phages to bacteria, including AI-based tools
- Strategies to overcome phage resistance
- Safe and well-characterized engineered phages
- Strong clinical trial designs and standardized treatment protocols
- Biomarkers to monitor patient response
- Scalable GMP production and quality control
- Regulatory frameworks that enable structured clinical use
- Rapid diagnostics and precision delivery systems
Selected projects will be presented during a dedicated Innovation Forum and evaluated by the scientific board jury.
Three Major Awards of Targeting Phage Therapy 2026
Scientific Innovation Award
For outstanding fundamental research advancing phage biology and mechanistic understanding.
Clinical Impact Award
For robust clinical work improving patient treatment, safety, and standardization.
Industrial & Translational Innovation Award
For technologies or production strategies that enable scalable, regulatory-compliant implementation.
For questions related to innovation participation, please click here to contact us.
Targeting Phage Therapy Team